- The Diagnostic Value of Serum Hyaluronic Acid, 7S Domain of Type IV Collagen and AST/ALT Ratio as Markers of Hepatic Fibrosis in Chronic Hepatitis B and Cirrhosis Patients
-
Park JH, Park CK, Kim ES, Park SY, Jo CM, Tak WY, Kweon YO, Kim SK, Choi YW
- KMID: 863141
- Korean J Hepatol.
- 2003 Jun;9(2):79-88.
BACKGROUND/AIMS: The prognosis of chronic liver disease is closely related to the development of hepatic fibrosis. Liver biopsy is the gold standard method to assess inflammatory activity and fibrosis... -
- CITED
-
- Close
- SHARE
-
- Close
- Prediction of Hepatic Fibrosis Using Serum Hyaluronic Acid in Patients with Chronic Liver Disease
-
Kim CW, Yoon SK, Jo BS, Shin JY, Jang JW, Choi JY, Han NI, Lee CD, Chung KW, Sun HS
- KMID: 1066042
- Korean J Gastroenterol.
- 2003 Dec;42(6):510-518.
BACKGROUND/AIMS: The extent of hepatic fibrosis is important in chronic liver disease. Liver biopsy is essential for diagnosis of fibrosis. However, biopsy is invasive and may not represent the... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum hyaluronic acid level: Correlation with quantitative measurement of hepatic fibrosis in a cirrhotic rat model
-
Kim MY, Baik SK, Jang YO, Suk KT, Kim JW, Kim HS, Cho MY, Choi SJ, Um SH, Han KH
- KMID: 760780
- Korean J Hepatol.
- 2008 Jun;14(2):159-167.
- doi: 10.3350/kjhep.2008.14.2.159
BACKGROUNDS/AIMS: The serum level of hyaluronic acid (HA) has been suggested as a useful serologic marker for hepatic fibrosis. However, the relationship between serum HA levels and quantitative markers... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of serum chondroitin sulfate and hyaluronan: biomarkers for osteoarthritis in canine hip dysplasia
-
Nganvongpanit K, Itthiarbha A, Ong-Chai S, Kongtawelert P
- KMID: 1718586
- J Vet Sci.
- 2008 Sep;9(3):317-325.
- doi: 10.4142/jvs.2008.9.3.317
Hip dysplasia (HD) is one of the most important bone and joint diseases in dogs. Making the radiographic diagnosis is sometime possible when the disease has markedly progressed. Chondroitin sulfate... -
- CITED
-
- Close
- SHARE
-
- Close
